BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15003821)

  • 1. Normal and malignant human plasma cells: proliferation, differentiation, and expansions in relation to CD45 expression.
    Pellat-Deceunynck C; Bataille R
    Blood Cells Mol Dis; 2004; 32(2):293-301. PubMed ID: 15003821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
    Pilarski LM; Jensen GS
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas.
    Fujii R; Ishikawa H; Mahmoud MS; Asaoku H; Kawano MM
    Br J Haematol; 1999 Apr; 105(1):131-40. PubMed ID: 10233376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Methoxyestradiol induce the conversion of human peripheral blood memory B lymphocytes into plasma cells.
    Cayer MP; Drouin M; Proulx M; Jung D
    J Immunol Methods; 2010 Apr; 355(1-2):29-39. PubMed ID: 20202470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders.
    Rodig SJ; Shahsafaei A; Li B; Dorfman DM
    Hum Pathol; 2005 Jan; 36(1):51-7. PubMed ID: 15712182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.
    Moreau P; Robillard N; Avet-Loiseau H; Pineau D; Morineau N; Milpied N; Harousseau JL; Bataille R
    Haematologica; 2004 May; 89(5):547-51. PubMed ID: 15136217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.
    Bataille R; Jégo G; Robillard N; Barillé-Nion S; Harousseau JL; Moreau P; Amiot M; Pellat-Deceunynck C
    Haematologica; 2006 Sep; 91(9):1234-40. PubMed ID: 16956823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.
    Kaiser S; Hackanson B; Follo M; Mehlhorn A; Geiger K; Ihorst G; Kapp U
    Cytotherapy; 2007; 9(5):439-50. PubMed ID: 17786605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Fushimi T; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2005 Mar; 12(1):33-40. PubMed ID: 16076609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
    Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow kinetic studies on three patients with myelomatosis. Indications for malignant proliferation within both the plasma cell and lymphoid cell compartments.
    Mellstedt H; Killander D; Pettersson D
    Acta Med Scand; 1977; 202(5):413-7. PubMed ID: 335796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.
    Traggiai E; Volpi S; Schena F; Gattorno M; Ferlito F; Moretta L; Martini A
    Stem Cells; 2008 Feb; 26(2):562-9. PubMed ID: 18024418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts.
    van Lochem EG; van der Velden VH; Wind HK; te Marvelde JG; Westerdaal NA; van Dongen JJ
    Cytometry B Clin Cytom; 2004 Jul; 60(1):1-13. PubMed ID: 15221864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromes.
    Ogata K; Satoh C; Tachibana M; Hyodo H; Tamura H; Dan K; Kimura T; Sonoda Y; Tsuji T
    Stem Cells; 2005 May; 23(5):619-30. PubMed ID: 15849169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
    Jensen GS; Mant MJ; Pilarski LM
    Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations.
    Arce S; Luger E; Muehlinghaus G; Cassese G; Hauser A; Horst A; Lehnert K; Odendahl M; Hönemann D; Heller KD; Kleinschmidt H; Berek C; Dörner T; Krenn V; Hiepe F; Bargou R; Radbruch A; Manz RA
    J Leukoc Biol; 2004 Jun; 75(6):1022-8. PubMed ID: 15020647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.